Three Keys To Mitigating Risk In Adaptive Trials

January 5, 2019

Adaptive trial designs can can accelerate timelines and reduce costs while simultaneously improving
program success rates. In this article, Sy Pretorius, Parexel's Senior Vice President and Chief Scientific Officer, offers insights about important steps to conduct successful adaptive trials.

Previous Flipbook
Learn about Parexel® Biotech
Learn about Parexel® Biotech

Focused on meeting customer and the patient needs with tailored, flexible solutions that speed up developme...

Next Flipbook
Drug development innovations that work: Adaptive trial design - BioPharma Dive
Drug development innovations that work: Adaptive trial design - BioPharma Dive